NCT02534506View on ClinicalTrials.gov

Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 6, 2015

Primary Completion Date

November 11, 2016

Study Completion Date

November 11, 2016

Conditions
Malignant Tumors
Interventions
DRUG

Urelumab

DRUG

Nivolumab

Trial Locations (1)

6500017

Local Institution, Kobe

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY